SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine

 SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine

SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine

Shots:

  • SMA Foundation and PTC will provide an initial investment of up to $60M in research to discover & develop regenerative treatments in neuromuscular diseases
  • The focus of the agreement is advance scientific research in SMA and other neuromuscular disorders to develop new treatments
  • The availability of several disease-modifying therapies has made regenerative interventions the next frontier in drug discovery and development

Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Wikipedia

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post